Allen, Wendy L.Dunne, Philip D.McDade, SimonScanlon, EnyaLoughrey, MauriceColeman, Helen G.McCann, ChristopheMcLaughlin, KristyNemeth, ZsuzsannaSyed, Najeeb AshrafJithesh, Puthen VeettilArthur, KenWilson, RichardCoyle, Vicky M.McArt, DarraghMurray, Graeme L.Samuel, LeslieNuciforo, PaoloJimenez, JoseArgiles, GuillemDienstmann, RodrigoTabernero, JosefPicariello, LuciaMesserini, LucaNobili, StefaniaMini, EnricoSheahan, KieranRyan, ElizabethJohnston, Patrick G.Van Schaeybroeck, SandraLawler, MarkLongley, Daniel B.2018-06-202018-06-202018-06-13Allen, W L, Dunne, P D, McDade, S, Scanlon, E, Loughrey, M, Coleman, H G, McCann, C, McLaughlin, K, Nemeth, Z, Syed, N A, Jithesh, P V, Arthur, K, Wilson, R, Coyle, V M, McArt, D, Murray, G L, Samuel, L, Nuciforo, P, Jimenez, J, Argiles, G, Dienstmann, R, Tabernero, J, Picariello, L, Messerini, L, Nobili, S, Mini, E, Sheahan, K, Ryan, E, Johnston, P G, Van Schaeybroeck, S, Lawler, M & Longley, D B 2018, 'Transcriptional Subtyping and CD8 Immunohistochemistry Identifies Patients With Stage II and III Colorectal Cancer With Poor Prognosis Who Benefit From Adjuvant Chemotherapy', JCO Precision Oncology, vol. 2, pp. 1-15. https://doi.org/10.1200/PO.17.002412473-4284ORCID: /0000-0002-8402-8670/work/50559782ORCID: /0000-0003-3981-2420/work/76973564PubMedCentral: PMC6040635http://hdl.handle.net/2164/10636This work was funded by Cancer Research UK: C212/A13721 and C11884/A24387151148092engSDG 3 - Good Health and Well-beingRC0254 Neoplasms. Tumors. Oncology (including Cancer)Cancer Research UKC212/A13721C11884/A24387Supplementary DataRC0254Journal article10.1200/PO.17.002412